This trial is not accepting new applicants

The study Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer is currently suspended. You can still browse other paid trials that may be a fit.